John Rondoni sold $1.7M of INSP
Chief Technology Officer at Inspire Medical Systems, Inc.. 8,703 shares at an average of $193.47, traded Nov 1, 2024, filed Nov 5, 2024.
Score components
- +15RoleOfficer
- +25Trade size$1.7M at market
- +10Share of holdings soldSold 43% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -3.7%, 3m -0.8%, 6m -18.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-24-114302, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 1, 2024 | MOption exercise Common Stock10b5-1 | +5,802 | $71.00 | $412k | 17,150 | Nov 5, 2024 |
| Nov 1, 2024 | MOption exercise Common Stock10b5-1 | +2,901 | $42.15 | $122k | 20,051 | Nov 5, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Stock10b5-1 | -5,777 | $192.93 | $1.1M | 14,274 | Nov 5, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Stock10b5-1 | -1,580 | $193.92 | $306k | 12,694 | Nov 5, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Stock10b5-1 | -1,013 | $194.84 | $197k | 11,681 | Nov 5, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Stock10b5-1 | -333 | $196.42 | $65k | 11,348 | Nov 5, 2024 |
| Nov 1, 2024 | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -5,802 | $0.00 | $0 | 1,448 | Nov 5, 2024 |
| Nov 1, 2024 | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -2,901 | $0.00 | $0 | 9,197 | Nov 5, 2024 |
Related signals
Other insiders at Inspire Medical Systems, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Inspire Medical Systems, Inc. | John Rondoni See Remarks | $11k 109 shares | -1% | |
| 6Weak | Inspire Medical Systems, Inc. | Shawn mcCormick director | $167k 1,200 shares | -5% | |
| 8Weak | Inspire Medical Systems, Inc. | Shawn mcCormick director | $255k 2,000 shares | -7% | |
| 24Weak | INSPbuy Inspire Medical Systems, Inc. | Myriam Curet director | $804 5 shares | +0% | |
| 30Weak | Inspire Medical Systems, Inc. | Myriam Curet director | $616 6 shares | -0% | |
| 52Moderate | INSPsell Inspire Medical Systems, Inc. | Richard Buchholz Chief Financial Officer | $1.0M 11,000 shares | -20% | |
| 41Moderate | Inspire Medical Systems, Inc. | John Rondoni See Remarks | $259k 1,734 shares | -11% | |
| 10Weak | Inspire Medical Systems, Inc. | Shawn mcCormick director | $58k 360 shares | -1% | |
| 34Weak | Inspire Medical Systems, Inc. | Randy Ban See Remarks | $733k 3,947 shares | -35% | |
| 24Weak | Inspire Medical Systems, Inc. | John Rondoni Chief Technology Officer | $424k 2,287 shares | -13% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.